Insights

Strategic Investment Recent Bay Area Lyme Ventures investment and licensing partnerships with Virginia Tourism Corporation and Virginia Tech indicate increasing investor and academic interest in Galaxy Diagnostics’ tick-borne disease diagnostics, presenting an opportunity to engage co-development and co-marketing discussions with investors and research partners.

Expansion Synergies North Carolina presence strengthened by strategic investment, suggesting a potential for expanding regional sales efforts with local healthcare providers, clinics, and research institutions that focus on vector-borne diseases in the southeastern U.S.

Product Leadership Flagship Nanotrap Urine test and the Bartonella IFA Serology Panel demonstrate advanced, sensitive diagnostics with direct detection capabilities, offering upsell opportunities to existing customers for expanded panels and to new labs seeking cutting-edge tick-borne diagnostics.

Multi-Channel Reach Technology stack and digital footprint indicate compatibility with partner marketing and sales automation (HubSpot, WordPress, analytics), enabling targeted campaigns to clinical labs, academic partners, and health systems seeking diagnostic innovations.

Financial Opportunity Revenue in the low-to-mid millions with modest funding, combined with strategic investments and licensing deals, suggests room to accelerate sales through channel partnerships, licensing expansions, and collaboration agreements with large diagnostics networks and research institutions.

Similar companies to Galaxy Diagnostics, Inc.

Galaxy Diagnostics, Inc. Tech Stack

Galaxy Diagnostics, Inc. uses 8 technology products and services including HubSpot Analytics, WordPress, Cart Functionality, and more. Explore Galaxy Diagnostics, Inc.'s tech stack below.

  • Content Management System
  • Cart Functionality
    E-commerce
  • Google Fonts API
    Font Scripts
  • Elementor
    Page Builders
  • Endurance Page Cache
    Web Platform Extensions
  • Twenty Twenty-One
    Web Platform Extensions

Media & News

Galaxy Diagnostics, Inc.'s Email Address Formats

Galaxy Diagnostics, Inc. uses at least 2 email formats:
Galaxy Diagnostics, Inc. Email FormatsExamplePercentage
First.Last@galaxydx.comJohn.Doe@galaxydx.com
84%
First@galaxydx.comJohn@galaxydx.com
16%

Frequently Asked Questions

What is Galaxy Diagnostics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Galaxy Diagnostics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Galaxy Diagnostics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Galaxy Diagnostics, Inc.'s official website is galaxydx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Galaxy Diagnostics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Galaxy Diagnostics, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Galaxy Diagnostics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Galaxy Diagnostics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Galaxy Diagnostics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Galaxy Diagnostics, Inc. has approximately 21 employees across 2 continents, including North America and Asia. Key team members include Laboratory Director: S. O., Principal: M. G. and Principal: M. G. Explore Galaxy Diagnostics, Inc.'s employee directory with LeadIQ.

What industry does Galaxy Diagnostics, Inc. belong to?

Minus sign iconPlus sign icon
Galaxy Diagnostics, Inc. operates in the Biotechnology Research industry.

What technology does Galaxy Diagnostics, Inc. use?

Minus sign iconPlus sign icon
Galaxy Diagnostics, Inc.'s tech stack includes HubSpot Analytics, WordPress, Cart Functionality, Microsoft 365, Google Fonts API, Elementor, Endurance Page Cache and Twenty Twenty-One.

What is Galaxy Diagnostics, Inc.'s email format?

Minus sign iconPlus sign icon
Galaxy Diagnostics, Inc.'s email format typically follows the pattern of First.Last@galaxydx.com. Find more Galaxy Diagnostics, Inc. email formats with LeadIQ.

How much funding has Galaxy Diagnostics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Galaxy Diagnostics, Inc. has raised $7.7M in funding. The last funding round occurred on May 22, 2025 for $4.1M.

When was Galaxy Diagnostics, Inc. founded?

Minus sign iconPlus sign icon
Galaxy Diagnostics, Inc. was founded in 2009.
Galaxy Diagnostics, Inc. logo

Galaxy Diagnostics, Inc.

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Galaxy Diagnostics, Inc. operates in the biotechnology research space, developing diagnostic tests for flea- and tick-borne infections with sensitivity that exceeds typical detection limits, including Bartonella and Lyme borreliosis. Its offerings include direct detection approaches for human health testing, such as the Nanotrap Urine Test introduced to confirm Lyme disease with greater sensitivity. The company is based in Durham, North Carolina, and maintains a focus on enabling more accurate diagnosis of vector-borne diseases.

In 2026, Galaxy Diagnostics announced a licensing agreement with Virginia Tech to advance Borrelia peptidoglycan antigen detection research for its diagnostic pipeline. Through collaborations and product development, the firm operates within the vector-borne disease diagnostics field, serving human health testing needs. As a smaller to mid-sized specialized biotechnology firm, it pursues ongoing innovation and partnerships to broaden its offerings in this niche.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $7.7M

    Galaxy Diagnostics, Inc. has raised a total of $7.7M of funding over 4 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $4.1M as a Venture Round.

  • $1M - $10M

    Galaxy Diagnostics, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.